These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19689277)

  • 1. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.
    Dean OM; van den Buuse M; Bush AI; Copolov DL; Ng F; Dodd S; Berk M
    Curr Med Chem; 2009; 16(23):2965-76. PubMed ID: 19689277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models.
    Kulak A; Steullet P; Cabungcal JH; Werge T; Ingason A; Cuenod M; Do KQ
    Antioxid Redox Signal; 2013 Apr; 18(12):1428-43. PubMed ID: 22938092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.
    Dean OM; van den Buuse M; Berk M; Copolov DL; Mavros C; Bush AI
    Neurosci Lett; 2011 Jul; 499(3):149-53. PubMed ID: 21621586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
    Gawryluk JW; Wang JF; Andreazza AC; Shao L; Young LT
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):123-30. PubMed ID: 20633320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder.
    Kulak A; Cuenod M; Do KQ
    Behav Brain Res; 2012 Jan; 226(2):563-70. PubMed ID: 22033334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radicals, antioxidant defense systems, and schizophrenia.
    Wu JQ; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():200-6. PubMed ID: 23470289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione.
    Das TK; Javadzadeh A; Dey A; Sabesan P; Théberge J; Radua J; Palaniyappan L
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Apr; 91():94-102. PubMed ID: 30125624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction and psychiatric disorders.
    Rezin GT; Amboni G; Zugno AI; Quevedo J; Streck EL
    Neurochem Res; 2009 Jun; 34(6):1021-9. PubMed ID: 18979198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivotal role of glutathione depletion in plasma-induced endothelial oxidative stress during sepsis.
    Huet O; Cherreau C; Nicco C; Dupic L; Conti M; Borderie D; Pene F; Vicaut E; Benhamou D; Mira JP; Duranteau J; Batteux F
    Crit Care Med; 2008 Aug; 36(8):2328-34. PubMed ID: 18664787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.
    Andreazza AC; Shao L; Wang JF; Young LT
    Arch Gen Psychiatry; 2010 Apr; 67(4):360-8. PubMed ID: 20368511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process.
    Mandal PK; Gaur S; Roy RG; Samkaria A; Ingole R; Goel A
    ACS Chem Neurosci; 2022 Oct; 13(19):2784-2802. PubMed ID: 36125113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry.
    Nucifora LG; Tanaka T; Hayes LN; Kim M; Lee BJ; Matsuda T; Nucifora FC; Sedlak T; Mojtabai R; Eaton W; Sawa A
    Transl Psychiatry; 2017 Aug; 7(8):e1215. PubMed ID: 28892069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mini-review: Brain energy metabolism and its role in animal models of depression, bipolar disorder, schizophrenia and autism.
    Kolar D; Kleteckova L; Brozka H; Vales K
    Neurosci Lett; 2021 Aug; 760():136003. PubMed ID: 34098028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of intracellular glutathione mediates butenolide-induced cytotoxicity in HepG2 cells.
    Wang YM; Peng SQ; Zhou Q; Wang MW; Yan CH; Yang HY; Wang GQ
    Toxicol Lett; 2006 Jul; 164(3):231-8. PubMed ID: 16495022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo glutathione levels in young persons with bipolar disorder: a magnetic resonance spectroscopy study.
    Lagopoulos J; Hermens DF; Tobias-Webb J; Duffy S; Naismith SL; White D; Scott E; Hickie IB
    J Psychiatr Res; 2013 Mar; 47(3):412-7. PubMed ID: 23312884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate.
    Bošković M; Grabnar I; Terzič T; Kores Plesničar B; Vovk T
    Psychiatry Res; 2013 Dec; 210(3):761-8. PubMed ID: 24041751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the role of glutathione in repin-induced mitochondrial dysfunction, oxidative stress and dopaminergic neurotoxicity in rat pheochromocytoma (PC12) cells.
    Tukov FF; Rimoldi JM; Matthews JC
    Neurotoxicology; 2004 Dec; 25(6):989-99. PubMed ID: 15474617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and therapeutic implications in psychiatric disorders.
    Zhang XY; Yao JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():197-9. PubMed ID: 23523744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance.
    Ross BM; Maxwell R; Glen I
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):446-53. PubMed ID: 21115087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder.
    Kuloglu M; Ustundag B; Atmaca M; Canatan H; Tezcan AE; Cinkilinc N
    Cell Biochem Funct; 2002 Jun; 20(2):171-5. PubMed ID: 11979513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.